West Pharmaceutical Services (WST) is Downgraded by Wells Fargo to Market Perform

West Pharmaceutical Services (WST) was Downgraded by Wells Fargo to ” Market Perform”. Earlier the firm had a rating of “Outperform ” on the company shares. Wells Fargo advised their investors in a research report released on Sep 21, 2016.

On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.

West Pharmaceutical Services (WST) witnessed a volatile trading activity on Tuesday , and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $82 and reached the intraday high at $82.11. The bulls started the profit booking and pushed the shares to intraday low of $81.305. The trading session was marked by a volume range of 3,70,854 shares exchanging hands. The 52-week high of the shares is $84.33 and the 52-week low is $52.79. The market cap of the company stands at $5,954 M and there are 7,32,17,998 shares in public circulation.

Investors should note that on Sep 12, 2016, West Pharmaceutical Services announced a cash dividend of $0.1300. The company’s management has announced Oct 17, 2016 as the ex-dividend date and fixed the record date on Oct 19, 2016. The payable date has been fixed on Nov 2, 2016.

In a different news, on Sep 7, 2016, Karen Flynn (Sr VP & Chief Commercial Offic) sold 14,581 shares at $83.28 per share price. According to the SEC, on Aug 24, 2016, Paula A Johnson (director) sold 3,042 shares at $81.55 per share price. On Jun 2, 2016, Daniel Malone (Vice President & Controller) sold 3,950 shares at $74.95 per share price, according to the Form-4 filing with the securities and exchange commission.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

West Pharmaceutical Services

Leave a Reply

West Pharmaceutical Services - Is it time to Sell?

Top Brokerage Firms are advising their investors on West Pharmaceutical Services. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.